Latest Payments News

Energy Resources of Australia Limited reported a substantial net cash outflow of $183.9 million in Q4 2024, driven by significant rehabilitation payments, while raising $766.5 million through equity to bolster its cash position.

West Wits Mining has increased its Mineral Resource Estimate by 749,000 ounces following a new Prospecting Right grant and appointed Rudi Deysel as CEO while advancing project financing for the Qala Shallows Gold Project.

Australian Oil Company Limited has secured an increased consideration in its Red Earth Assets divestment, receiving A$660,000 upfront while deferring A$540,000 to March 2025.

IperionX has completed its inaugural end-to-end titanium powder production cycle using its proprietary HAMR process and secured exclusive rights to breakthrough titanium technologies, positioning itself for expanded manufacturing capacity and strong market demand.

Rox Resources has advanced its Youanmi Gold Project with a $27 million capital raise and a major drilling campaign, positioning the company for production by late 2025.

Empire Energy Group Limited reported a significant cash outflow of $14.2 million in the December 2024 quarter, driven by exploration and evaluation activities, yet maintains a strong liquidity position with nearly $54 million in available funding.

EMVision Medical Devices reports strong progress in clinical trials for its emu™ Bedside Scanner, backed by robust cash reserves and strategic non-dilutive funding. The company is poised to commence pivotal FDA validation trials, marking a key step toward commercialisation.

EBR Systems has signed a long-term lease for a 51,000 sq ft facility in Santa Clara, California, positioning itself for significant manufacturing expansion and future growth in wireless cardiac pacing technology.

BrainChip Holdings reports a US$20 million cash balance and key defense contracts in its December 2024 quarterly update, underscoring its growing foothold in neuromorphic AI commercialization.

Dimerix Limited has inked a lucrative licensing agreement with Fuso Pharmaceutical for its kidney disease drug DMX-200 in Japan, while completing recruitment for its pivotal Phase 3 ACTION3 trial.

Bellevue Gold Limited reported a $52 million net cash outflow from operating activities in the December 2024 quarter, alongside a substantial $112.6 million early repayment on its project loan facility, leaving $79.45 million in cash reserves.

Butn Limited has posted record quarterly revenue and platform originations for Q2 FY25, alongside sustained positive operating cash flow, signaling robust growth and strategic expansion into crypto-backed lending.